Skip to main content
Erschienen in: Journal of Neurology 10/2016

09.03.2016 | Review

Chronic idiopathic axonal polyneuropathy: a systematic review

verfasst von: Panagiotis Zis, Ptolemaios Georgios Sarrigiannis, Dasappaiah Ganesh Rao, Channa Hewamadduma, Marios Hadjivassiliou

Erschienen in: Journal of Neurology | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Chronic idiopathic axonal polyneuropathy (CIAP) is a term describing neuropathies with both sensory and motor involvement in a length dependant distribution where neurophysiology reveals axonal damage, neuropathy onset is insidious and shows slow or no progression of the disease over at least 6 months with no aetiology being identified despite appropriate investigations. This entity merits further consideration given how common it is, the absence of clarity regarding aetiopathogenesis, natural history and therapies. A systematic computer-based literature search was conducted on PubMed database. We used two Medical Subject Headings terms in title. Term A was “axonal”, “cryptogenic”, “idiopathic” or “unknown” and Term B was “neuropathy” or “polyneuropathy”. This search strategy resulted in the identification of 658 articles. After eligibility assessment, 48 papers were used for this review. CIAP is usually diagnosed in the sixth decade of life and it is more prevalent in males (ratio 3:2). It is usually slowly progressive. Some data support a potential role of autoimmunity in CIAP and further larger prospective studies are required to address such potential link and any treatment implications. CIAP is a common type of polyneuropathy but the least studied. Increasing awareness and research into this entity may result in better understanding and in the development of treatment strategies.
Literatur
2.
Zurück zum Zitat Hughes RA (2002) Peripheral neuropathy. BMJ (Clini Res ed) 324(7335):466–469CrossRef Hughes RA (2002) Peripheral neuropathy. BMJ (Clini Res ed) 324(7335):466–469CrossRef
3.
Zurück zum Zitat Sveen KA, Karime B, Jorum E, Mellgren SI, Fagerland MW, Monnier VM et al (2013) Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study. Diabetes Care 36(11):3712–3717PubMedPubMedCentralCrossRef Sveen KA, Karime B, Jorum E, Mellgren SI, Fagerland MW, Monnier VM et al (2013) Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study. Diabetes Care 36(11):3712–3717PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Marquez-Infante C, Murphy SM, Mathew L, Alsanousi A, Lunn MP, Brandner S et al (2013) Asymmetric sensory ganglionopathy: a case series. Muscle Nerve 48(1):145–150PubMedCrossRef Marquez-Infante C, Murphy SM, Mathew L, Alsanousi A, Lunn MP, Brandner S et al (2013) Asymmetric sensory ganglionopathy: a case series. Muscle Nerve 48(1):145–150PubMedCrossRef
6.
Zurück zum Zitat Visser NA, Notermans NC, Degen LA, de Kruijk JR, van den Berg LH, Vrancken AF (2014) Chronic idiopathic axonal polyneuropathy and vitamin B6: a controlled population-based study. J Periph Nerv Syst JPNS 19(2):136–144CrossRef Visser NA, Notermans NC, Degen LA, de Kruijk JR, van den Berg LH, Vrancken AF (2014) Chronic idiopathic axonal polyneuropathy and vitamin B6: a controlled population-based study. J Periph Nerv Syst JPNS 19(2):136–144CrossRef
7.
Zurück zum Zitat Lindh J, Tondel M, Osterberg A, Vrethem M (2005) Cryptogenic polyneuropathy: clinical and neurophysiological findings. J Periph Nerv Syst JPNS 10(1):31–37CrossRef Lindh J, Tondel M, Osterberg A, Vrethem M (2005) Cryptogenic polyneuropathy: clinical and neurophysiological findings. J Periph Nerv Syst JPNS 10(1):31–37CrossRef
8.
Zurück zum Zitat Vrancken AF, Franssen H, Wokke JH, Teunissen LL, Notermans NC (2002) Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system in elderly people. Arch Neurol 59(4):533–540PubMedCrossRef Vrancken AF, Franssen H, Wokke JH, Teunissen LL, Notermans NC (2002) Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system in elderly people. Arch Neurol 59(4):533–540PubMedCrossRef
9.
Zurück zum Zitat Teunissen LL, Notermans NC, Franssen H, van der Graaf Y, Oey PL, Linssen WH et al (1997) Differences between hereditary motor and sensory neuropathy type 2 and chronic idiopathic axonal neuropathy. A clinical and electrophysiological study. Brain J Neurol 120(Pt 6):955–962CrossRef Teunissen LL, Notermans NC, Franssen H, van der Graaf Y, Oey PL, Linssen WH et al (1997) Differences between hereditary motor and sensory neuropathy type 2 and chronic idiopathic axonal neuropathy. A clinical and electrophysiological study. Brain J Neurol 120(Pt 6):955–962CrossRef
10.
Zurück zum Zitat Wolfe GI, Baker NS, Amato AA, Jackson CE, Nations SP, Saperstein DS et al (1999) Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics. Arch Neurol 56(5):540–547CrossRef Wolfe GI, Baker NS, Amato AA, Jackson CE, Nations SP, Saperstein DS et al (1999) Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics. Arch Neurol 56(5):540–547CrossRef
11.
Zurück zum Zitat Erdmann PG, van Genderen FR, Teunissen LL, Notermans NC, Lindeman E, van Wijck AJ et al (2010) Pain in patients with chronic idiopathic axonal polyneuropathy. Eur Neurol 64(1):58–64PubMedCrossRef Erdmann PG, van Genderen FR, Teunissen LL, Notermans NC, Lindeman E, van Wijck AJ et al (2010) Pain in patients with chronic idiopathic axonal polyneuropathy. Eur Neurol 64(1):58–64PubMedCrossRef
12.
13.
Zurück zum Zitat Notermans NC, Wokke JH, van den Berg LH, van der Graaf Y, Franssen H, Teunissen LL et al (1996) Chronic idiopathic axonal polyneuropathy. Comparison of patients with and without monoclonal gammopathy. Brain J Neurol 119(Pt 2):421–427CrossRef Notermans NC, Wokke JH, van den Berg LH, van der Graaf Y, Franssen H, Teunissen LL et al (1996) Chronic idiopathic axonal polyneuropathy. Comparison of patients with and without monoclonal gammopathy. Brain J Neurol 119(Pt 2):421–427CrossRef
14.
Zurück zum Zitat Notermans NC, Wokke JH, van der Graaf Y, Franssen H, van Dijk GW, Jennekens FG (1994) Chronic idiopathic axonal polyneuropathy: a five year follow up. J Neurol Neurosurg Psychiatry 57(12):1525–1527PubMedPubMedCentralCrossRef Notermans NC, Wokke JH, van der Graaf Y, Franssen H, van Dijk GW, Jennekens FG (1994) Chronic idiopathic axonal polyneuropathy: a five year follow up. J Neurol Neurosurg Psychiatry 57(12):1525–1527PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Notermans NC, Wokke JH, Franssen H, van der Graaf Y, Vermeulen M, van den Berg LH et al (1993) Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 56(10):1066–1071PubMedPubMedCentralCrossRef Notermans NC, Wokke JH, Franssen H, van der Graaf Y, Vermeulen M, van den Berg LH et al (1993) Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 56(10):1066–1071PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Bharucha NE, Bharucha AE, Bharucha EP (1991) Prevalence of peripheral neuropathy in the Parsi community of Bombay. Neurology 41(8):1315–1317PubMedCrossRef Bharucha NE, Bharucha AE, Bharucha EP (1991) Prevalence of peripheral neuropathy in the Parsi community of Bombay. Neurology 41(8):1315–1317PubMedCrossRef
17.
Zurück zum Zitat Italian General Practitioner Study Group (IGPSG) (1995) Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Neurology 45(10):1832–1836 Italian General Practitioner Study Group (IGPSG) (1995) Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Neurology 45(10):1832–1836
18.
Zurück zum Zitat Rosenberg NR, Vermeulen M (2004) Chronic idiopathic axonal polyneuropathy revisited. J Neurol 251(9):1128–1132PubMedCrossRef Rosenberg NR, Vermeulen M (2004) Chronic idiopathic axonal polyneuropathy revisited. J Neurol 251(9):1128–1132PubMedCrossRef
19.
Zurück zum Zitat Smith AG, Singleton JR (2004) The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy. Arch Intern Med 164(9):1021–1025PubMedCrossRef Smith AG, Singleton JR (2004) The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy. Arch Intern Med 164(9):1021–1025PubMedCrossRef
20.
Zurück zum Zitat Singer MA, Vernino SA, Wolfe GI (2012) Idiopathic neuropathy: new paradigms, new promise. J Periph Nerv Syst JPNS 17(Suppl 2):43–49CrossRef Singer MA, Vernino SA, Wolfe GI (2012) Idiopathic neuropathy: new paradigms, new promise. J Periph Nerv Syst JPNS 17(Suppl 2):43–49CrossRef
21.
Zurück zum Zitat Vilming ST, Stave R (1987) Idiopathic polyneuropathy. A prospective study including gastrointestinal investigation. J Oslo City Hosp 37(11–12):129–134 Vilming ST, Stave R (1987) Idiopathic polyneuropathy. A prospective study including gastrointestinal investigation. J Oslo City Hosp 37(11–12):129–134
22.
Zurück zum Zitat Rajabally YA, Shah RS (2011) Dyslipidaemia in chronic acquired distal axonal polyneuropathy. J Neurol 258(8):1431–1436PubMedCrossRef Rajabally YA, Shah RS (2011) Dyslipidaemia in chronic acquired distal axonal polyneuropathy. J Neurol 258(8):1431–1436PubMedCrossRef
23.
Zurück zum Zitat Sachedina S, Toth C (2013) Progression in idiopathic, diabetic, paraproteinemic, alcoholic, and B12 deficiency neuropathy. J Periph Nerv Syst JPNS 18(3):247–255CrossRef Sachedina S, Toth C (2013) Progression in idiopathic, diabetic, paraproteinemic, alcoholic, and B12 deficiency neuropathy. J Periph Nerv Syst JPNS 18(3):247–255CrossRef
24.
Zurück zum Zitat Latov N, Kumar G, Vo ML, Chin RL, Carey BT, Langsdorf JA et al (2015) Elevated blood mercury levels in idiopathic axonal neuropathy. JAMA Neurol 72(4):474–475PubMedCrossRef Latov N, Kumar G, Vo ML, Chin RL, Carey BT, Langsdorf JA et al (2015) Elevated blood mercury levels in idiopathic axonal neuropathy. JAMA Neurol 72(4):474–475PubMedCrossRef
25.
Zurück zum Zitat Tondel M, Lindh J, Jonsson P, Vrethem M, Persson B (2006) Occupational determinants of cryptogenic polyneuropathy. Neuroepidemiology 26(4):187–194PubMedCrossRef Tondel M, Lindh J, Jonsson P, Vrethem M, Persson B (2006) Occupational determinants of cryptogenic polyneuropathy. Neuroepidemiology 26(4):187–194PubMedCrossRef
26.
Zurück zum Zitat Smith AG (2012) Impaired glucose tolerance and metabolic syndrome in idiopathic neuropathy. J Periph Nerv Syst JPNS 17(Suppl 2):15–21CrossRef Smith AG (2012) Impaired glucose tolerance and metabolic syndrome in idiopathic neuropathy. J Periph Nerv Syst JPNS 17(Suppl 2):15–21CrossRef
27.
Zurück zum Zitat Novella SP, Inzucchi SE, Goldstein JM (2001) The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 24(9):1229–1231PubMedCrossRef Novella SP, Inzucchi SE, Goldstein JM (2001) The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 24(9):1229–1231PubMedCrossRef
28.
Zurück zum Zitat Singleton JR, Smith AG, Bromberg MB (2001) Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24(8):1448–1453PubMedCrossRef Singleton JR, Smith AG, Bromberg MB (2001) Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24(8):1448–1453PubMedCrossRef
29.
Zurück zum Zitat Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M (2003) The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60(1):108–111PubMedCrossRef Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M (2003) The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60(1):108–111PubMedCrossRef
30.
Zurück zum Zitat Hoffman-Snyder C, Smith BE, Ross MA, Hernandez J, Bosch EP (2006) Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy. Arch Neurol 63(8):1075–1079PubMedCrossRef Hoffman-Snyder C, Smith BE, Ross MA, Hernandez J, Bosch EP (2006) Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy. Arch Neurol 63(8):1075–1079PubMedCrossRef
31.
Zurück zum Zitat Nebuchennykh M, Loseth S, Jorde R, Mellgren SI (2008) Idiopathic polyneuropathy and impaired glucose metabolism in a Norwegian patient series. Euro J Neurol Off J Euro Feder Neurol Soc 15(8):810–816 Nebuchennykh M, Loseth S, Jorde R, Mellgren SI (2008) Idiopathic polyneuropathy and impaired glucose metabolism in a Norwegian patient series. Euro J Neurol Off J Euro Feder Neurol Soc 15(8):810–816
32.
33.
Zurück zum Zitat Singleton JR, Smith AG, Bromberg MB (2001) Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 24(9):1225–1228PubMedCrossRef Singleton JR, Smith AG, Bromberg MB (2001) Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 24(9):1225–1228PubMedCrossRef
34.
Zurück zum Zitat American Diabetes Association (2010) Standards of medical care in diabetes–2010. Diabetes Care 33(Suppl 1):S11–S61 American Diabetes Association (2010) Standards of medical care in diabetes–2010. Diabetes Care 33(Suppl 1):S11–S61
35.
Zurück zum Zitat Hughes RA, Umapathi T, Gray IA, Gregson NA, Noori M, Pannala AS et al (2004) A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain J Neurol 127(Pt 8):1723–1730CrossRef Hughes RA, Umapathi T, Gray IA, Gregson NA, Noori M, Pannala AS et al (2004) A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy. Brain J Neurol 127(Pt 8):1723–1730CrossRef
36.
Zurück zum Zitat Gaist D, Jeppesen U, Andersen M, Garcia Rodriguez LA, Hallas J, Sindrup SH (2002) Statins and risk of polyneuropathy: a case-control study. Neurology 58(9):1333–1337PubMedCrossRef Gaist D, Jeppesen U, Andersen M, Garcia Rodriguez LA, Hallas J, Sindrup SH (2002) Statins and risk of polyneuropathy: a case-control study. Neurology 58(9):1333–1337PubMedCrossRef
37.
Zurück zum Zitat Anderson JL, Muhlestein JB, Bair TL, Morris S, Weaver AN, Lappe DL et al (2005) Do statins increase the risk of idiopathic polyneuropathy? Am J Cardiol 95(9):1097–1099PubMedCrossRef Anderson JL, Muhlestein JB, Bair TL, Morris S, Weaver AN, Lappe DL et al (2005) Do statins increase the risk of idiopathic polyneuropathy? Am J Cardiol 95(9):1097–1099PubMedCrossRef
38.
Zurück zum Zitat Fitchett D (2015) The metabolic syndrome is an important concept in therapeutic decision-making. Canadian J Cardiol 31(5):596–600CrossRef Fitchett D (2015) The metabolic syndrome is an important concept in therapeutic decision-making. Canadian J Cardiol 31(5):596–600CrossRef
39.
Zurück zum Zitat Visser NA, Vrancken AF, van der Schouw YT, van den Berg LH, Notermans NC (2013) Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome. Diabetes Care 36(4):817–822PubMedPubMedCentralCrossRef Visser NA, Vrancken AF, van der Schouw YT, van den Berg LH, Notermans NC (2013) Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome. Diabetes Care 36(4):817–822PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Rezania K, Soliven B, Rezai KA, Roos RP (2011) Impaired glucose tolerance and metabolic syndrome in idiopathic polyneuropathy: the role of pain and depression. Med Hypotheses 76(4):538–542PubMedCrossRef Rezania K, Soliven B, Rezai KA, Roos RP (2011) Impaired glucose tolerance and metabolic syndrome in idiopathic polyneuropathy: the role of pain and depression. Med Hypotheses 76(4):538–542PubMedCrossRef
41.
Zurück zum Zitat Teunissen LL, Franssen H, Wokke JH, van der Graaf Y, Linssen WH, Banga JD et al (2002) Is cardiovascular disease a risk factor in the development of axonal polyneuropathy? J Neurol Neurosurg Psychiatry 72(5):590–595PubMedPubMedCentralCrossRef Teunissen LL, Franssen H, Wokke JH, van der Graaf Y, Linssen WH, Banga JD et al (2002) Is cardiovascular disease a risk factor in the development of axonal polyneuropathy? J Neurol Neurosurg Psychiatry 72(5):590–595PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Merlini G, Palladini G (2012) Differential diagnosis of monoclonal gammopathy of undetermined significance. Hematol Edu Prog Am Soc Hematol Am Soc Hematol Edu Prog 2012:595–603 Merlini G, Palladini G (2012) Differential diagnosis of monoclonal gammopathy of undetermined significance. Hematol Edu Prog Am Soc Hematol Am Soc Hematol Edu Prog 2012:595–603
43.
Zurück zum Zitat Gorson KC, Ropper AH (1997) Axonal neuropathy associated with monoclonal gammopathy of undetermined significance. J Neurol Neurosurg Psychiatry 63(2):163–168PubMedPubMedCentralCrossRef Gorson KC, Ropper AH (1997) Axonal neuropathy associated with monoclonal gammopathy of undetermined significance. J Neurol Neurosurg Psychiatry 63(2):163–168PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Eurelings M, van den Berg LH, Wokke JH, Franssen H, Vrancken AF, Notermans NC (2003) Increase of sural nerve T cells in progressive axonal polyneuropathy and monoclonal gammopathy. Neurology 61(5):707–709PubMedCrossRef Eurelings M, van den Berg LH, Wokke JH, Franssen H, Vrancken AF, Notermans NC (2003) Increase of sural nerve T cells in progressive axonal polyneuropathy and monoclonal gammopathy. Neurology 61(5):707–709PubMedCrossRef
45.
Zurück zum Zitat Gherardi RK, Farcet JP, Creange A, Claudepierre P, Malapert D, Authier FJ et al (1998) Dominant T-cell clones of unknown significance in patients with idiopathic sensory neuropathies. Neurology 51(2):384–389PubMedCrossRef Gherardi RK, Farcet JP, Creange A, Claudepierre P, Malapert D, Authier FJ et al (1998) Dominant T-cell clones of unknown significance in patients with idiopathic sensory neuropathies. Neurology 51(2):384–389PubMedCrossRef
46.
Zurück zum Zitat Wolfe GI, El-Feky WH, Katz JS, Bryan WW, Wians FH Jr, Barohn RJ (1997) Antibody panels in idiopathic polyneuropathy and motor neuron disease. Muscle Nerve 20(10):1275–1283PubMedCrossRef Wolfe GI, El-Feky WH, Katz JS, Bryan WW, Wians FH Jr, Barohn RJ (1997) Antibody panels in idiopathic polyneuropathy and motor neuron disease. Muscle Nerve 20(10):1275–1283PubMedCrossRef
47.
Zurück zum Zitat Kelkar P, McDermott WR, Parry GJ (2002) Sensory-predominant, painful, idiopathic neuropathy: inflammatory changes in sural nerves. Muscle Nerve 26(3):413–416PubMedCrossRef Kelkar P, McDermott WR, Parry GJ (2002) Sensory-predominant, painful, idiopathic neuropathy: inflammatory changes in sural nerves. Muscle Nerve 26(3):413–416PubMedCrossRef
48.
Zurück zum Zitat Sobue G, Yasuda T, Kachi T, Sakakibara T, Mitsuma T (1993) Chronic progressive sensory ataxic neuropathy: clinicopathological features of idiopathic and Sjogren’s syndrome-associated cases. J Neurol 240(1):1–7PubMedCrossRef Sobue G, Yasuda T, Kachi T, Sakakibara T, Mitsuma T (1993) Chronic progressive sensory ataxic neuropathy: clinicopathological features of idiopathic and Sjogren’s syndrome-associated cases. J Neurol 240(1):1–7PubMedCrossRef
49.
Zurück zum Zitat Teunissen LL, Notermans NC, Jansen GH, Banga JD, Veldman H, Wokke JH (2000) Thickness of endoneurial vessel basal lamina area in chronic idiopathic axonal polyneuropathy. Acta Neuropathol 100(4):445–450PubMedCrossRef Teunissen LL, Notermans NC, Jansen GH, Banga JD, Veldman H, Wokke JH (2000) Thickness of endoneurial vessel basal lamina area in chronic idiopathic axonal polyneuropathy. Acta Neuropathol 100(4):445–450PubMedCrossRef
50.
Zurück zum Zitat Vrancken AF, Notermans NC, Jansen GH, Wokke JH, Said G (2004) Progressive idiopathic axonal neuropathy–a comparative clinical and histopathological study with vasculitic neuropathy. J Neurol 251(3):269–278PubMedCrossRef Vrancken AF, Notermans NC, Jansen GH, Wokke JH, Said G (2004) Progressive idiopathic axonal neuropathy–a comparative clinical and histopathological study with vasculitic neuropathy. J Neurol 251(3):269–278PubMedCrossRef
51.
Zurück zum Zitat Erdmann PG, Teunissen LL, van Genderen FR, Notermans NC, Lindeman E, Helders PJ et al (2007) Functioning of patients with chronic idiopathic axonal polyneuropathy (CIAP). J Neurol 254(9):1204–1211PubMedPubMedCentralCrossRef Erdmann PG, Teunissen LL, van Genderen FR, Notermans NC, Lindeman E, Helders PJ et al (2007) Functioning of patients with chronic idiopathic axonal polyneuropathy (CIAP). J Neurol 254(9):1204–1211PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Teunissen LL, Eurelings M, Notermans NC, Hop JW, van Gijn J (2000) Quality of life in patients with axonal polyneuropathy. J Neurol 247(3):195–199PubMedCrossRef Teunissen LL, Eurelings M, Notermans NC, Hop JW, van Gijn J (2000) Quality of life in patients with axonal polyneuropathy. J Neurol 247(3):195–199PubMedCrossRef
53.
Zurück zum Zitat Lindh J, Tondel M, Persson B, Vrethem M (2011) Health-related quality of life in patients with cryptogenic polyneuropathy compared with the general population. Disabil Rehabil 33(7):617–623PubMedCrossRef Lindh J, Tondel M, Persson B, Vrethem M (2011) Health-related quality of life in patients with cryptogenic polyneuropathy compared with the general population. Disabil Rehabil 33(7):617–623PubMedCrossRef
54.
Zurück zum Zitat Rudolph T, Larsen JP, Farbu E (2009) Is there a need for long-term follow-up in chronic idiopathic polyneuropathy? Acta Neurol Scand 120(5):347–352PubMedCrossRef Rudolph T, Larsen JP, Farbu E (2009) Is there a need for long-term follow-up in chronic idiopathic polyneuropathy? Acta Neurol Scand 120(5):347–352PubMedCrossRef
55.
Zurück zum Zitat Takeuchi H, Misu K, Hattori N, Nagamatsu M, Sobue G (2000) Immunoglobulin therapy for idiopathic chronic sensory ataxic neuropathy. Neurology 54(4):1008–1010PubMedCrossRef Takeuchi H, Misu K, Hattori N, Nagamatsu M, Sobue G (2000) Immunoglobulin therapy for idiopathic chronic sensory ataxic neuropathy. Neurology 54(4):1008–1010PubMedCrossRef
56.
Zurück zum Zitat Deleplanque P, Pourrat O, Alcalay D, Robert R, Neau JP, Gil R (1990) Treatment of idiopathic chronic polyneuropathy with plasma exchange alone. Prog Clin Biol Res 337:293–296PubMed Deleplanque P, Pourrat O, Alcalay D, Robert R, Neau JP, Gil R (1990) Treatment of idiopathic chronic polyneuropathy with plasma exchange alone. Prog Clin Biol Res 337:293–296PubMed
57.
Zurück zum Zitat Coyle PK, Schutzer SE, Sterman AB, Peress N, Miller F (1985) Humoral abnormalities in three patients with idiopathic chronic polyneuropathy. New York State J Med 85(6):248–250 Coyle PK, Schutzer SE, Sterman AB, Peress N, Miller F (1985) Humoral abnormalities in three patients with idiopathic chronic polyneuropathy. New York State J Med 85(6):248–250
58.
Zurück zum Zitat Uncini A, Sabatelli M, Mignogna T, Lugaresi A, Liguori R, Montagna P (1996) Chronic progressive steroid responsive axonal polyneuropathy: a CIDP vaariant or a primary axonal disorder? Muscle Nerve 19(3):365–371PubMedCrossRef Uncini A, Sabatelli M, Mignogna T, Lugaresi A, Liguori R, Montagna P (1996) Chronic progressive steroid responsive axonal polyneuropathy: a CIDP vaariant or a primary axonal disorder? Muscle Nerve 19(3):365–371PubMedCrossRef
59.
Zurück zum Zitat Vrancken AF, van Schaik IN, Hughes RA, Notermans NC (2004) Drug therapy for chronic idiopathic axonal polyneuropathy. Cochrane Database Syst Rev 2004(2):Cd003456 Vrancken AF, van Schaik IN, Hughes RA, Notermans NC (2004) Drug therapy for chronic idiopathic axonal polyneuropathy. Cochrane Database Syst Rev 2004(2):Cd003456
60.
Zurück zum Zitat Attal N, Cruccu G, Baron R, Haanpaa M, Hansson P, Jensen TS et al (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Euro J Neurol Off J Euro Feder Neurol Soc 17(9):1113-e88 Attal N, Cruccu G, Baron R, Haanpaa M, Hansson P, Jensen TS et al (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Euro J Neurol Off J Euro Feder Neurol Soc 17(9):1113-e88
61.
Zurück zum Zitat Herrmann DN, Barbano RL, Hart-Gouleau S, Pennella-Vaughan J, Dworkin RH (2005) An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy. Pain Med (Malden, Mass) 6(5):379–384 Herrmann DN, Barbano RL, Hart-Gouleau S, Pennella-Vaughan J, Dworkin RH (2005) An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy. Pain Med (Malden, Mass) 6(5):379–384
62.
Zurück zum Zitat Schroder C, Johnston M, Teunissen L, Notermans N, Helders P, van Meeteren N (2007) Perceived control is a concurrent predictor of activity limitations in patients with chronic idiopathic axonal polyneuropathy. Arch Phys Med Rehabil 88(1):63–69PubMedCrossRef Schroder C, Johnston M, Teunissen L, Notermans N, Helders P, van Meeteren N (2007) Perceived control is a concurrent predictor of activity limitations in patients with chronic idiopathic axonal polyneuropathy. Arch Phys Med Rehabil 88(1):63–69PubMedCrossRef
Metadaten
Titel
Chronic idiopathic axonal polyneuropathy: a systematic review
verfasst von
Panagiotis Zis
Ptolemaios Georgios Sarrigiannis
Dasappaiah Ganesh Rao
Channa Hewamadduma
Marios Hadjivassiliou
Publikationsdatum
09.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 10/2016
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-016-8082-7

Weitere Artikel der Ausgabe 10/2016

Journal of Neurology 10/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.